Engineering Graphene for developing Neural Interfaces to revolutionize how we treat neurological diseases

INBRAIN Neuroelectronics is developing AI-powered graphene-based neural implants to enhance resolution and specificity in neuroelectronic therapies for refractory neurological disorders.

Subsidie
€ 2.493.750
2023

Projectdetails

Introduction

Neurological disorders represent one of the greatest healthcare challenges for our society, with 1 billion affected people worldwide.

Challenges in Current Treatments

25-35% of these patients are refractory to pharmacological therapy and are left with no options. Neuroelectronic therapies, aimed at recording and stimulating brain activity to restore normal brain function, are emerging as a safe alternative for them.

Limitations of Current Neuroelectronic Implants

However, current neuroelectronic implants are made of big metal leads with multiple limitations, such as:

  • Poor resolution
  • Low specificity
  • High invasiveness

Our Solution

We, at INBRAIN Neuroelectronics, have the solution. We are developing a complete platform of intelligent neuroelectronic interface systems powered by Graphene dots.

Innovations in Neural Implants

We are developing graphene-based neural implants that, powered by AI, will have the capability of:

  1. Reading single neural cells at a resolution never seen before
  2. Detecting therapy-specific biomarkers
  3. Triggering adaptive responses for increased outcomes in personalized neurological therapies

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.493.750
Totale projectbegroting€ 3.562.500

Tijdlijn

Startdatum1-5-2023
Einddatum30-4-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • INBRAIN NEUROELECTRONICS SLpenvoerder

Land(en)

Geen landeninformatie beschikbaar

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation

CorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030.

€ 2.500.000
EIC Accelerator

NAO.VNS: A New Personalized Neural Stimulation Therapy For Drug-resistant Epilepsy

NAO.VNS is an innovative implantable vagus nerve stimulator using optical fibers to enhance treatment for drug-resistant epilepsy, enabling personalized therapy and remote monitoring, with market approval expected by 2028.

€ 2.499.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Minimally Invasive Neuromodulation Implant and implantation procedure based on ground-breaking GRAPHene technology for treating brain disorders

The MINIGRAPH project aims to revolutionize neuromodulation therapy for brain diseases by developing minimally invasive, personalized brain implants with closed-loop capabilities and high-resolution graphene microelectrodes.

€ 4.428.402
EIC Transition

Graphene Transistors for High-Density Brain-Computer Interfaces

The project develops graphene-based transistors for high-resolution brain mapping and monitoring, aiming to enhance brain-computer interfaces with fewer wires and better integration.

€ 2.495.000
ERC Starting...

Soft optoelectronics and ion-based circuits for diagnostics and closed-loop neuromodulation of the auditory pathway

Develop a fully implantable, biocompatible electro-optical neurostimulation system using ion gated transistors and OLEDs to enhance neural signal acquisition and treatment of sensory dysfunctions.

€ 1.499.213
EIC Pathfinder

MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation

META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.

€ 2.987.655
EIC Pathfinder

BioFunctional IntraNeural Electrodes

BioFINE aims to develop advanced flexible intraneural multielectrode arrays for improved long-term integration with peripheral nerves, enhancing bionic limb communication and neurotechnology.

€ 1.945.622